OQRO

Tela Bio

TELA · NASDAQ · Health Care · Surgical & Medical Instruments & Apparatus

Surgical & Medical Instruments & Apparatus company based in Malvern, Pa.

Example public filing

SEC Form 4

Director bought ~$58K

Joseph H Capper, Director at Tela Bio, bought ~$58K of Tela Bio shares.

~$58K
Approx. value · 50K sh @ $1.17
155K
Holds after · shares reported
Traded
Sep 16, 2026
Filed
Sep 19, 2026

Data as of Oct 11, 2026. A real record from the official source, chosen as the most recent insider trade or, failing that, the most recent filing of another kind; not a recommendation.

On file for TELA, last 12 months

59
Insider filings
0
Congress trades
0
Fund positions
0
Federal contracts

Records OQRO holds, counted by their date; a 13F position is counted once per quarter it is reported.

Insider buying and selling since 2019

Insiders of Tela Bio reported 248 open-market purchases and 7 sales since 2019; purchases in 8 different years, most recently 2026.

YearBoughtSold
2026
6×
—
2025
1×
—
2024
3×
3×
2023
3×
3×
2022
127×
—
2021
74×
—
2020
26×
—
2019
8×
1×

Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. The amounts, the people and every filing are in OQRO Pro.

See the full picture with OQRO Pro.

59 records for Tela Bio in the last 12 months, each linked to its filing. Full histories, the screener, alerts for the companies you follow and Ask OQRO.

Latest disclosures

SourceWhoAction
Unlock full access — $9.99/month

Secure payment by Stripe. Renews every month until you cancel; cancel anytime from your account. No free trial.

Continue exploring the free preview

Public previews are free. Full research requires Pro. No free trial.

What this page holds

  • Insider trades and planned sales
  • Politician trades (House and Senate)
  • Fund holdings from 13F filings
  • Federal contracts, lobbying and short selling
  • Full history and context, with a link to every filing

What OQRO is

OQRO reads the public record for US-listed companies — insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings, and federal contract awards — and puts each one in plain words next to the filing it came from. It describes what was disclosed. It does not give investment advice or tell you what to buy.

Want to see real filings before you pay? The home page shows live ones, free, with the link to each source document.

Questions about Tela Bio insider trading

Have Tela Bio insiders bought shares recently?

Yes. Insiders of Tela Bio (TELA) filed 6 open-market purchases in the last 90 days; the latest was filed on Sep 19, 2026.

How often do Tela Bio insiders buy and sell shares?

Since 2019, Tela Bio insiders reported 248 open-market purchases and 7 sales on Forms 4 and 5, with purchases in 8 different years, most recently 2026.

Do members of Congress trade TELA?

No trade in Tela Bio (TELA) was disclosed by a member of Congress in the last 12 months.

When does Tela Bio report its next results?

Tela Bio's next results are expected on Nov 11, 2026. The date can move until the company confirms it. Insiders often trade in the weeks right after results.

Where does this data come from?

From official filings only: SEC Forms 4, 5 and 144 for insiders, House and Senate periodic transaction reports for Congress, SEC Form 13F for funds, Form 8-K for company events and USAspending for federal contracts. Every record on OQRO links to its source. It is public data, not investment advice.

What this filing is, free to read